Journal List > Ann Clin Microbiol > v.23(1) > 1144291

Sohn, Byun, Kim, Shin, and Lee: Season and Temperature Effects on Bloodstream Infection Incidence in a Korean Tertiary Referral Hospital

Abstract

Background

The weather has well-documented effects on infectious disease and reports suggest that summer peaks in the incidences of gram-negative bacterial infections among hospitalized patients. We evaluated how season and temperature changes affect bloodstream infection (BSI) incidences of major pathogens to understand BSI trends with an emphasis on

Methods

Incidence rates of BSIs by Staphylococcus aureus, Enterococcus spp., Escherichia coli, Klebsiella pneumoniae, Acinetobacter spp., and Pseudomonas aeruginosa were retrospectively analyzed from blood cultures during 2008–2016 at a university hospital in Seoul, Korea according to the acquisition sites. Warm months (June–September) had an average temperature of ≥20 °C and cold months (December–February) had an average temperature of ≤5 °C.

Results

We analyzed 18,047 cases, where 43% were with community-onset BSI. E. coli (N = 5,365) was the most common pathogen, followed byEnterococcus spp. (N = 3,980),S. aureus (N = 3,075), K. pneumoniae (N = 3,043),Acinetobacter spp. (N = 1,657), andP. aeruginosa (N = 927). The incidence of hospital-acquired BSI byEnterococcus spp. was weakly correlated with temperature, and the median incidence was higher during cold months. The incidence of community-onset BSI by E. coli was higher in warm months and was weakly correlated with temperature.

Conclusion

We found seasonal or temperature-associated variation in some species-associated BSIs. This could be a useful information for enhancing infection control and public health policies by taking season or climate into consideration.

References

1. Fisman DN. Seasonality of infectious diseases. Annu Rev Public Health. 2007; 28:127–43.
crossref
2. Polgreen PM, Polgreen EL. Infectious diseases, weather, and climate. Clin Infect Dis. 2018; 66:815–7.
crossref
3. Eber MR, Shardell M, Schweizer ML, Laxminarayan R, Perencevich EN. Seasonal and temperature-associated increases in gram-negative bacterial bloodstream infections among hospitalized patients. PLoS One. 2011; 6:e25298.
crossref
4. Perencevich EN, McGregor JC, Shardell M, Furuno JP, Harris AD, Morris JG, et al. Summer peaks in the incidences of gram-negative bacterial infection among hospitalized patients. Infect Control Hosp Epidemiol. 2008; 29:1124–31.
crossref
5. Retailliau HF, Hightower AW, Dixon RE, Allen JR. Acinetobacter calcoaceticus: a nosocomial pathogen with an unusual seasonal pattern. J Infect Dis. 1979; 139:371–5.
crossref
6. Richet H. Seasonality in gram-negative and healthcare-associated infections. Clin Microbiol Infect. 2012; 18:934–40.
crossref
7. Rodrigues FS, Clemente de Luca FA, Ribeiro da Cunha A, Fortaleza CMCB. Seasons, weather and predictors of healthcare-associated gram-negative bloodstream infections: a case-only study. J Hosp Infect. 2019; 101:134–41.
8. Kim YA, Kim JJ, Won DJ, Lee K. Seasonal and temperature-associated increase in community-onset Acinetobacter baumannii complex colonization or infection. Ann Lab Med. 2018; 38:266–70.
crossref
9. Flournoy DJ, Stalling FH, Catron TL. Seasonal and monthly variation of Streptococcus pneumoniae and other pathogens in bacteremia (1961–1981). Ecol Dis. 1983; 2:157–60.
10. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, et al. Healthcare-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002; 137:791–7.
11. Colpan A, Johnston B, Porter S, Clabots C, Anway R, Thao L, et al. Escherichia coli Sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clin Infect Dis. 2013; 57:1256–65.
crossref
12. Kim YA, Kim JJ, Kim H, Lee K. Community-onset extended-spectrum-β-lactamase-producing Escherichia coli sequence type 131 at two Korean community hospitals: the spread of multidrug-resistant E. coli to the community via healthcare facilities. Int J Infect Dis. 2017; 54:39–42.
crossref
13. Spellberg B, Doi Y. Editor's choice: the rise of fluoroquinolone-resistant Escherichia coli in the community: scarier than we thought. J Infect Dis. 2015; 212:1853–5.
14. Lazarus B, Paterson DL, Mollinger JL, Rogers BA. Do human extraintestinal Escherichia coli infections resistant to expanded-spectrum cephalosporins originate from food-producing animals? a systematic review. Clin Infect Dis. 2014; 60:439–52.
crossref
15. Eveillard M, Kempf M, Belmonte O, Pailhoriès H, Joly-Guillou ML. Reservoirs of Acinetobacter baumannii outside the hospital and potential involvement in emerging human community-acquired infections. Int J Infect Dis. 2013; 17:e802–5.
crossref
16. Lee Y, Kim YA, Song W, Lee H, Lee HS, Jang SJ, et al. Recent trends in antimicrobial resistance in intensive care units in Korea. Korean J Nosocomial Infect Control. 2014; 19:29–36.
crossref
17. Ratkowsky D, Lowry R, McMeekin T, Stokes A, Chandler R. Model for bacterial culture growth rate throughout the entire biokinetic temperature range. J Bacteriol. 1983; 154:1222–6.
crossref
18. Raetz CR, Reynolds CM, Trent MS, Bishop RE. Lipid a modification systems in gram-negative bacteria. Annu Rew Bochem. 2007; 76:295–329.
crossref
19. Yang J, Bae S, Park C, Lee K. Presented at the Korean society of infectious diseases and Korean society of antimicrobial therapy. 2018.
20. Ahn GY, Lee SH, Jeong OY, Chaulagain BP, Moon DS, Park YJ. Trends of the species and antimicrobial susceptibility of microorganisms isolated from blood cultures of patients. Korean J Clin Microbiol. 2006; 9:42–50.
21. Kim N, Hwang J, Song K, Choe PG, Park WB, Kim ES, et al. Changes in antimicrobial susceptibility of blood isolates in a university hospital in South Korea, 1998–2010. Infect Chemother. 2012; 44:275–81.
crossref
22. Kim SY, Lim G, Kim MJ, Suh JT, Lee HJ. Trends in five-year blood cultures of patients at a university hospital (2003∼ 2007). Korean J Clin Microbiol. 2009; 12:163–8.

Fig. 1.
Correlation between bloodstream infection (BSI) by gram-positive cocci and average monthly temperature from 2008–2016 based on Pearson's correlation coefficient. (a) Temperature (°C) vs. incidence rate of community-onset BSI by S. aureus (cases per 105 patient days), y = 0.00337x+1.774, r = 0.0565, P = 0.5612. (b) Temperature (°C) vs. incidence rate of hospital-acquired BSI by S. aureus (cases per 106 patient days), y = 0.0588x+29.781, r = 0.0444, P = 0.6484. (c) Temperature (°C) vs. incidence rate of community-onset BSI by Enterococcus spp. (cases per 105 patient days), y = 0.0488x+9.558, r = 0.0952, P = 0.3273. (d) Temperature (°C) vs. incidence rate of hospital-acquired BSI by Enterococcus spp. (cases per 106 patient days), y = −0.495x+59.061, r = −0.3020, P = 0.0015. CA, community-onset; HA, hospital-acquired; Temp., temperature.
acm-23-33f1.tif
Fig. 2.
Correlation between bloodstream infection (BSI) by gram-negative bacilli and average monthly temperature from 2008–2016 based on Pearson's correlation coefficient. (a) Temperature (°C) vs. incidence rate of community-onset BSI by E. coli (cases per 105 patient days), y = 0.540x+52.754, r = 0.3304, P = 0.0005. (b) Temperature (°C) vs. incidence rate of hospital-acquired BSI by E. coli (cases per 106 patient days), y = 0.128x+23.142, r = 0.1443, P = 0.1363. (c) Temperature (°C) vs. incidence rate of community-onset BSI by K. pneumoniae (cases per 105 patient days), y = 0.193x+22.874, r = 0.1986, P = 0.0394. (d) Temperature (°C) vs. incidence rate of hospital-acquired BSI by K. pneumoniae (cases per 106 patient days), y = 0.124x+20.931, r = 0.1094, P = 0.2596. CO, community-onset; HA, hospital-acquired; Temp., temperature.
acm-23-33f2.tif
Fig. 3.
Correlation between bloodstream infection (BSI) by glucose non-fermenters and average monthly temperature from 2008–2016. (a) Temperature (°C) vs. incidence rate of community-onset BSI by Acinetobacter spp. (cases per 105 patient days), y = 0.0500x+2.065, r = 0.2100, P = 0.0292. (b) Temperature (°C) vs. incidence rate of hospital-acquired BSI by Acinetobacter spp. (cases per 106 patient days), y = −0.121x+25.202, r = −0.1148, P = 0.2368. (c) Temperature (°C) vs. incidence rate of community-onset BSI by P. aeruginosa (cases per 105 patient days), y = 0.000520x+0.455, r = 0.0137, P = 0.8879. (d) Temperature (°C) vs. incidence rate of hospital-acquired BSI by P. aeruginosa (cases per 106 patient days), y = 0.0565x+8.814, r = −0.0957, P = 0.3241. CO, community-onset; HA, hospital-acquired; Temp., temperature.
acm-23-33f3.tif
Table 1.
Etiologic agents of bloodstream infections according to acquisition site (2008–2016)
Year S. aureus Enterococcus spp. E. coli K. pneumoniae Acinetobacter spp. P. aeruginosa
  Total CO HA CO/ HA Total CO HA CO/ HA Total CO HA CO/ HA Total CO HA CO/ HA Total CO HA CO/ HA Total CO HA CO/ HA
2008 256 93 163 0.6 368 54 314 0.2 443 313 130 2.4 191 106 85 1.2 160 15 145 0.1 113 44 69 0.6
2009 338 109 229 0.5 365 45 320 0.1 494 340 154 2.2 263 147 116 1.3 247 15 232 0.1 175 50 125 0.4
2010 272 120 152 0.8 395 62 333 0.2 453 328 125 2.6 223 116 107 1.1 144 15 129 0.1 85 32 53 0.6
2011 395 114 281 0.4 508 54 454 0.1 586 346 240 1.4 430 195 235 0.8 164 17 147 0.1 102 47 55 0.9
2012 319 139 180 0.8 347 55 292 0.2 490 358 132 2.7 292 167 125 1.3 202 20 182 0.1 80 22 58 0.4
2013 369 112 257 0.4 508 102 406 0.3 619 461 158 2.9 413 206 207 1.0 240 29 211 0.1 94 30 64 0.5
2014 312 139 173 0.8 476 93 383 0.2 678 497 181 2.7 351 204 147 1.4 167 21 146 0.1 84 23 61 0.4
2015 373 167 206 0.8 461 84 377 0.2 766 559 207 2.7 403 230 173 1.3 171 23 148 0.2 95 35 60 0.6
2016 441 160 281 0.6 552 98 454 0.2 836 596 240 2.5 477 242 235 1.0 162 15 147 0.1 99 44 55 0.8
9 years 3,075 1,153 1,922 0.6 3,980 647 3,333 0.2 5,365 3,798 1,567 2.4 3,043 1,613 1 1,430 1.1 1,657 170 1,487 0.1 927 327 600 0.5

Abbreviation: CO, community-onset; HA, hospital-acquired.

Table 2.
Incidence of community-onset bloodstream infections according to acquisition site and seasonal changes
Etiologic agents Community-onset (cases per 105 patient days)
Warm months Cold months P
M 95% CI IQR M 95% CI IQR
S. aureus 17.88 16.16–20.01 13.96–20.92 16.80 15.63–19.17 15.25–20.37 0.6769
Enterococcus spp. 0.98 0.61–1.25 0.51–1.48 0.87 0.66–1.12 0.60–1.26 0.6871
E. coli 60.40 54.90–77.60 53.10–81.30 52.70 47.80–55.80 41.10–61.50 0.0044
K. pneumoniae 28.20 25.00–32.50 20.90–33.70 22.50 20.10–26.10 17.00–27.90 0.0518
Acinetobacter spp. 3.34 1.74–4.01 1.68–5.07 1.68 0.00–3.38 0.00–3.84 0.0672
P. aeruginosa 0.35 0.19–0.70 0.17–0.85 0.40 0.33–0.69 0.31–0.78 0.5976

Abbreviation: M, median; CI, confidence interval; IQR, interquartile range.

Table 3.
Incidence of hospital-acquired bloodstream infections according to acquisition site and seasonal changes
Etiologic agents Hospital-acquired (cases per 106 patient days)
Warm months Cold month s P
M 95% CI IQR M 95% CI IQR
S. aureus 29.10 24.90–33.70 22.50–37.10 26.90 23.60–32.70 20.80–34.70 0.6467
Enterococcus spp. 45.20 39.60–47.30 37.90–51.50 57.20 49.80–63.90 48.90–65.60 0.0021
E. coli 25.40 22.50–30.70 20.60–31.50 24.20 17.10–28.20 16.90–31.20 0.3241
K. pneumoniae 23.50 18.40–28.40 16.90–30.50 19.80 13.90–25.30 13.70–27.10 0.1965
Acinetobacter spp. 20.90 17.22–25.69 13.80–27.70 26.60 21.59–28.60 19.70–31.40 0.0956
P. aeruginosa 8.87 6.74–11.52 5.57–12.70 7.97 5.69–11.55 5.13–12.31 0.3241

Abbreviation: M, median; CI, confidence interval; IQR, interquartile range.

TOOLS
Similar articles